In vitro pathological modelling using patient-specific induced pluripotent stem cells: The case of progeria

Biochemical Society Transactions

Volumn 39, Issue 6, 2011, Pages 1775-1779

  Nissan, Xavier ^a   Blondel, Sophie ^a   Peschanski, Marc ^a  

^a I Stem   (France)

Author keywords

Aging; Hutchinson Gilford progeria syndrome (HGPS); Induced pluripotent stem cell (IPSC); Lamin A C; Progeria

Indexed keywords

DOUBLE STRANDED DNA; KRUPPEL LIKE FACTOR 4; LAMIN A; LAMIN C; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

CONFERENCE PAPER; DISEASE MODEL; DNA REPAIR; DOUBLE STRANDED DNA BREAK; EMBRYONIC STEM CELL; FIBROBLAST; HUMAN; IN VITRO STUDY; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROGERIA; PROTEIN EXPRESSION;

HUMANS; INDUCED PLURIPOTENT STEM CELLS; MODELS, BIOLOGICAL; PROGERIA;

EID: 81855198150     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20110659     Document Type: Conference Paper

References (50)

1. Hennekam, R.C. (2006) Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A 140, 2603-2624
2. De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M. and Lévy, N. (2003) Lamin A truncation in Hutchinson-Gilford progeria. Science 300, 2055 (Pubitemid 36760124)
3. Burke, B. and Stewart, C.L. (2006) The laminopathies: the functional architecture of the nucleus and its contribution to disease. Annu. Rev. Genomics Hum. Genet. 7, 369-405 (Pubitemid 44627935)
4. Cao, K., Capell, B.C., Erdos, M.R., Djabali, K. and Collins, F.S. (2007) A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc. Natl. Acad. Sci. U.S.A. 104, 4949-4954 (Pubitemid 47186157)
5. Goldman, R.D., Shumaker, D.K., Erdos, M.R., Eriksson, M., Goldman, A.E., Gordon, L.B., Gruenbaum, Y., Khuon, S., Mendez, M., Varga, R. and Collins, F.S. (2004) Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. U.S.A. 101, 8963-8968 (Pubitemid 38781594)
6. Musich, P.R. and Zou, Y. (2009) Genomic instability and DNA damage responses in progeria arising from defective maturation of prelamin A. Ageing 1, 28-37
7. Liu, B., Wang, J., Chan, K.M., Tjia, W.M., Deng, W., Guan, X., Huang, J.D., Li, K.M., Chau, P.Y., Chen, D.J. et al. (2005) Genomic instability in laminopathy-based premature ageing. Nat. Med. 11, 780-785 (Pubitemid 41021211)
8. Manju, K., Muralikrishna, B. and Parnaik, V.K. (2006) Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. J. Cell Sci. 119, 2704-2714 (Pubitemid 44184007)
9. Decker, M.L., Chavez, E., Vulto, I. and Lansdorp, P.M. (2009) Telomere length in Hutchinson-Gilford progeria syndrome. Mech. Ageing Dev. 130, 377-383
10. Navarro, C.L., Cau, P. and Lévy, N. (2006) Molecular bases of progeroid syndromes. Hum. Mol. Genet. 15 (Suppl. 2), R151-R161 (Pubitemid 44446788)
11. Pereira, S., Bourgeois, P., Navarro, C., Esteves-Vieira, V., Cau, P., De Sandre-Giovannoli, A. and Lévy, N. (2008) HGPS and related premature ageing disorders: from genomic identification to the first therapeutic approaches. Mech. Ageing Dev. 129, 449-459
12. Agrawal, A.G. and Somani, R.R. (2009) Farnesyltransferase inhibitor as anticancer agent. Mini Rev. Med. Chem. 9, 638-652
13. Toth, J.I., Yang, S.H., Qiao, X., Belgneux, A.P., Gelb, M.H., Moulson, C.L., Miner, J.H., Young, S.G. and Fong, L.G. (2005) Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc. Natl. Acad. Sci. U.S.A. 102, 12873-12878 (Pubitemid 41279458)
14. Capell, B.C., Erdos, M.R., Madigan, J.P., Fiordalisi, J.J., Varga, R., Conneely, K.N., Gordon, L.B., Der, C.J., Cox, A.D. and Collins, F.S. (2005) Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc. Natl. Acad. Sci. U.S.A. 102, 12879-12884 (Pubitemid 41282816)
15. Yang, S.H., Bergo, M.O., Toth, J.I., Qiao, X., Hu, Y., Sandoval, S., Meta, M., Bendale, P., Gelb, M.H., Young, S.G. and Fong, L.G. (2005) Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc. Natl. Acad. Sci. U.S.A. 102, 10291-10296 (Pubitemid 41023365)
16. Constantinescu, D., Csoka, A.B., Navara, C.S. and Schatten, G.P. (2010) Defective DSB repair correlates with abnormal nuclear morphology and is improved with FTI treatment in Hutchinson-Gilford progeria syndrome fibroblasts. Exp. Cell Res. 316, 2747-2759
17. Capell, B.C., Olive, M., Erdos, M.R., Cao, K., Faddah, D.A., Tavarez, U.L., Conneely, K.N., Qu, X., San, H., Ganesh, S.K. et al. (2008) A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model. Proc. Natl. Acad. Sci. U.S.A. 105, 15902-15907
18. Yang, S.H., Meta, M., Qiao, X., Frost, D., Bauch, J., Coffinier, C., Majumdar, S., Bergo, M.O., Young, S.G. and Fong, L.G. (2006) A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J. Clin. Invest. 116, 2115-2121 (Pubitemid 44162320)
19. Varela, I., Pereira, S., Ugalde, A.P., Navarro, C.L., Suárez, M.F., Cau, P., Cadiñanos, J., Osorio, F.G., Foray, N., Cobo, J. et al. (2008) Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature ageing. Nat. Med. 14, 767-772
20. Russell, R.G., Watts, N.B., Ebetino, F.H. and Rogers, M.J. (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporosis Int. 19, 733-759
21. Harrison, D.E., Strong, R., Sharp, Z.D., Nelson, J.F., Astle, C.M., Flurkey, K., Nadon, N.L., Wilkinson, J.E., Frenkel, K., Carter, C.S. et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460, 392-395
22. Cao, K., Graziotto, J.J., Blair, C.D., Mazzulli, J.R., Erdos, M.R., Krainc, D. and Collins, F.S. (2011) Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci. Transl. Med. 3, 89ra58
23. Paradisi, M., McClintock, D., Boguslavsky, R.L., Pedicelli, C., Worman, H.J. and Djabali, K. (2005) Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC Cell Biol. 6, 27
24. Scaffidi, P. and Misteli, T. (2008) Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat. Cell Biol. 10, 452-459
25. Osorio, F.G., Obaya, A.J., Lopéz-Otin, C. and Freije, J.M. (2009) Accelerated ageing: from mechanism to therapy through animal models. Transgenic Res. 18, 7-15
26. Liu, G.H., Barkho, B.Z., Ruiz, S., Diep, D., Qu, J., Yang, S.L., Panopoulos, A.D., Suzuki, K., Kurian, L., Walsh, C. et al. (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472, 221-225
27. Liu, G.H., Suzuki, K., Qu, J., Sancho-Martinez, I., Yi, F., Li, M., Kumar, S., Nivet, E., Kim, J., Soligalla, R.D. et al. (2011) Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell 8, 688-694
28. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., Mutalif, R.A., Navasankari, R., Zhang, Y., Tse, H.F. et al. (2011) A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell 8, 31-45
29. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S. and Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (Pubitemid 28516247)
30. Mateizel, I., De Temmerman, N., Ullmann, U., Cauffman, G., Sermon, K., Van de Velde, H., De Rycke, M., Degreef, E., Devroey, P., Liebaers, I. and Van Steirteghem, A. (2006) Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum. Reprod. 21, 503-511 (Pubitemid 43159929)
31. Mateizel, I., Spits, C., De Rycke, M., Liebaers, I. and Sermon, K. (2010) Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell. Dev. Biol. Anim. 46, 300-308
32. Eiges, R., Urbach, A., Malcov, M., Frumkin, T., Schwartz, T., Amit, A., Yaron, Y., Eden, A., Yanuka, O., Benvenisty, N. and Ben-Yosef, D. (2007) Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 1, 568-577 (Pubitemid 350079966)
33. Marteyn, A., Maury, Y., Gauthier, M.M., Lecuyer, C., Vernet, R., Denis, J.A., Pietu, G., Peschanski, M. and Martinat, C. (2011) Mutant human embryonic stem cells reveal neurite and synapse formation defects in type 1 myotonic dystrophy. Cell Stem Cell 8, 434-444
34. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (Pubitemid 350138099)
35. Colman, A. and Dreesen, O. (2009) Pluripotent stem cells and disease modelling. Cell Stem Cell 5, 244-247
36. Hanna, J., Wernig, M., Markoulaki, S., Sun, C.W., Meissner, A., Cassady, J.P., Beard, C., Brambrink, T., Wu, L.C., Townes, T.M. and Jaenisch, R. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923
37. Wernig, M., Zhao, J.P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., Broccoli, V., Constantine-Paton, M., Isacson, O. and Jaenisch, R. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 105, 5856-5861 (Pubitemid 351758462)
38. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R. et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221
39. Ebert, A.D., Yu, J., Rose, Jr, F.F., Mattis, V.B., Lorson, C.L., Thomson, J.A. and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280
40. Ho, J.C., Zhou, T., Lai, W.H., Huang, Y., Chan, Y.C., Li, X., Wong, N.L., Li, Y., Au, K.W., Guo, D. et al. (2011) Generation of induced pluripotent stem cell lines from 3 distinct laminopathies bearing heterogeneous mutations in lamin A/C. Ageing 3, 380-390
41. Broers, J.L., Machiels, B.M., Kuijpers, H.J., Smedts, F., van den Kieboom, R., Raymond, Y. and Ramaekers, F.C. (1997) A- and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol. 107, 505-517 (Pubitemid 27306980)
42. Panopoulos, A.D., Ruiz, S. and Izpisúa Belmonte, J.C. (2011) iPSCs: induced back to controversy. Cell Stem Cell 8, 347-348
43. Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. and Hochedlinger, K. (2008) Induced pluripotent stem cells generated without viral integration. Science 322, 945-949
44. Lyssiotis, C.A., Foreman, R.K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L.L., Charette, B.D., Bouchez, L.C. et al. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. U.S.A. 106, 8912-8917
45. Warren, L., Manos, P.D., Ahfeldt, T., Loh, Y.H., Li, H., Lau, F., Ebina, W., Mandal, P.K., Smith, Z.D., Meissner, A. et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630
46. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, II and Thomson, J.A. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801
47. Zhou, H., Wu, S., Joo, J.Y., Zhu, S., Han, D.W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y. et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384
48. Lee, G., Papapetrou, E.P., Kim, H., Chambers, S.M., Tomishima, M.J., Fasano, C.A., Ganat, Y.M., Menon, J., Shimizu, F., Viale, A. et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402-406
49. Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H. et al. (2011) Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229
50. Scaffidi, P. and Misteli, T. (2006) Lamin A-dependent nuclear defects in human ageing. Science 312, 1059-1063